Cargando…
Extensively Drug-Resistant Salmonella enterica serovar Typhi in Pediatric population during CoVID-19 Pandemic
PURPOSE: The Extensively Drug-resistant (XDR) Salmonella isolates exhibiting resistance to the first line and the second-line antibiotic options are presently a grave public health concern in Pakistan. Here, we report the first large-scale emergence and spread of an XDR S. Typhi in Peshawar, Pakista...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884783/ http://dx.doi.org/10.1016/j.ijid.2021.12.010 |
_version_ | 1784660241060724736 |
---|---|
author | Khan, M. Tu-Zahra, F. Gul, A. Saleem, M.Z. Riaz, M. Gul, W. |
author_facet | Khan, M. Tu-Zahra, F. Gul, A. Saleem, M.Z. Riaz, M. Gul, W. |
author_sort | Khan, M. |
collection | PubMed |
description | PURPOSE: The Extensively Drug-resistant (XDR) Salmonella isolates exhibiting resistance to the first line and the second-line antibiotic options are presently a grave public health concern in Pakistan. Here, we report the first large-scale emergence and spread of an XDR S. Typhi in Peshawar, Pakistan during Coronavirus disease (CoVID-19) pandemic. Initially XDR typhoid cases were reported during post rainy season but now the disease has become endemic during winter months. METHODS & MATERIALS: From December 2020 till January 2021, we reported the high level of emerging resistance to different groups of antibiotics among Salmonella isolates from paediatric age group with enteric fever. A total of 548 blood cultures from symptomatic patients were submitted to Microbiology section of Pathology Laboratory, Rehman Medical Institute, Peshawar. All samples were incubated in BACTEC 9240 and processed according to standard guidelines (sub-cultured on Blood and MacConkey's agar and non-lactose fermenting colonies were biochemically tested for Salmonella typhi and confirmed by Salmonella specific anti-sera. Demographic data including age, gender, address and clinical features were also recorded. RESULTS: Salmonella Typhi was isolated in 71 and 548 blood samples during December 2020 and January 2021, out of which 66 (92.9%) and 5% (7%) were MDR, respectively. All isolates revealed high level of resistance to co-trimaxazole (93%) and complete resistance to chloramphenicol (100%), ampicillin (100%), ciprofloxacin (100%), ceftriaxone (100%), cefixime (100%). All XDR typhoid isolates were sensitive to azithromycin and carbapenems. The children under 15 years’ age (88%) has a significantly high prevalence among children as compared to adults (p=0.0016), males (76%) were affected more than females (24%). CONCLUSION: The emergence of XDR S. typhi with high level of resistance is quite alarming. With inadequate treatments options, the present situation calls for immediate effective preventive measures including food and water safety, improved sanitation, public awareness sessions and typhoid vaccination campaigns. |
format | Online Article Text |
id | pubmed-8884783 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88847832022-03-01 Extensively Drug-Resistant Salmonella enterica serovar Typhi in Pediatric population during CoVID-19 Pandemic Khan, M. Tu-Zahra, F. Gul, A. Saleem, M.Z. Riaz, M. Gul, W. Int J Infect Dis Op01.09 (1017) PURPOSE: The Extensively Drug-resistant (XDR) Salmonella isolates exhibiting resistance to the first line and the second-line antibiotic options are presently a grave public health concern in Pakistan. Here, we report the first large-scale emergence and spread of an XDR S. Typhi in Peshawar, Pakistan during Coronavirus disease (CoVID-19) pandemic. Initially XDR typhoid cases were reported during post rainy season but now the disease has become endemic during winter months. METHODS & MATERIALS: From December 2020 till January 2021, we reported the high level of emerging resistance to different groups of antibiotics among Salmonella isolates from paediatric age group with enteric fever. A total of 548 blood cultures from symptomatic patients were submitted to Microbiology section of Pathology Laboratory, Rehman Medical Institute, Peshawar. All samples were incubated in BACTEC 9240 and processed according to standard guidelines (sub-cultured on Blood and MacConkey's agar and non-lactose fermenting colonies were biochemically tested for Salmonella typhi and confirmed by Salmonella specific anti-sera. Demographic data including age, gender, address and clinical features were also recorded. RESULTS: Salmonella Typhi was isolated in 71 and 548 blood samples during December 2020 and January 2021, out of which 66 (92.9%) and 5% (7%) were MDR, respectively. All isolates revealed high level of resistance to co-trimaxazole (93%) and complete resistance to chloramphenicol (100%), ampicillin (100%), ciprofloxacin (100%), ceftriaxone (100%), cefixime (100%). All XDR typhoid isolates were sensitive to azithromycin and carbapenems. The children under 15 years’ age (88%) has a significantly high prevalence among children as compared to adults (p=0.0016), males (76%) were affected more than females (24%). CONCLUSION: The emergence of XDR S. typhi with high level of resistance is quite alarming. With inadequate treatments options, the present situation calls for immediate effective preventive measures including food and water safety, improved sanitation, public awareness sessions and typhoid vaccination campaigns. Published by Elsevier Ltd. 2022-03 2022-02-28 /pmc/articles/PMC8884783/ http://dx.doi.org/10.1016/j.ijid.2021.12.010 Text en Copyright © 2021 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Op01.09 (1017) Khan, M. Tu-Zahra, F. Gul, A. Saleem, M.Z. Riaz, M. Gul, W. Extensively Drug-Resistant Salmonella enterica serovar Typhi in Pediatric population during CoVID-19 Pandemic |
title | Extensively Drug-Resistant Salmonella enterica serovar Typhi in Pediatric population during CoVID-19 Pandemic |
title_full | Extensively Drug-Resistant Salmonella enterica serovar Typhi in Pediatric population during CoVID-19 Pandemic |
title_fullStr | Extensively Drug-Resistant Salmonella enterica serovar Typhi in Pediatric population during CoVID-19 Pandemic |
title_full_unstemmed | Extensively Drug-Resistant Salmonella enterica serovar Typhi in Pediatric population during CoVID-19 Pandemic |
title_short | Extensively Drug-Resistant Salmonella enterica serovar Typhi in Pediatric population during CoVID-19 Pandemic |
title_sort | extensively drug-resistant salmonella enterica serovar typhi in pediatric population during covid-19 pandemic |
topic | Op01.09 (1017) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884783/ http://dx.doi.org/10.1016/j.ijid.2021.12.010 |
work_keys_str_mv | AT khanm extensivelydrugresistantsalmonellaentericaserovartyphiinpediatricpopulationduringcovid19pandemic AT tuzahraf extensivelydrugresistantsalmonellaentericaserovartyphiinpediatricpopulationduringcovid19pandemic AT gula extensivelydrugresistantsalmonellaentericaserovartyphiinpediatricpopulationduringcovid19pandemic AT saleemmz extensivelydrugresistantsalmonellaentericaserovartyphiinpediatricpopulationduringcovid19pandemic AT riazm extensivelydrugresistantsalmonellaentericaserovartyphiinpediatricpopulationduringcovid19pandemic AT gulw extensivelydrugresistantsalmonellaentericaserovartyphiinpediatricpopulationduringcovid19pandemic |